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Abstract
Background: To determine, from October 2010 to October 2018, the epidemiology of Deep Neck Infections (DNIs),
regarding the detection, the identification and the susceptibility to antimicrobials of causative microorganisms, in
Thessaly-Central Greece.
Methods: An analysis of data from a prospective database was conducted on 610 consecutive patients with DNIs
treated in the Otolaryngology / Head & Neck Surgery Department of University Hospital of Larissa. Demographics,
clinical features and microbiological data were analyzed.
Results: Among the 610 patients (1,9/1 male to female ratio, mean age: 39,24 ± 17,25) with DNIs, 579 had a single
space (94,9%), while the remaining 31 had a multi-space (5,1%) DNI. The most common areas affected were the
peritonsillar space (84,6%) followed by the submandibular space (6,5%). Clinical samples were obtained from 462
patients, and were tested by culture and by the application of 16S rRNA PCR. Two hundred fifty-five samples (55,
2%) gave positive cultures, in which Streptococcus pyogenes and Staphylococcus aureus were predominant. The
application of the 16S rRNA PCR revealed that 183 samples (39,6%) were positive for bacterial DNA; 22 of them,
culture negative, were found to be positive for anaerobic (Fusobacterium necrophorum, Actinomyces israellii etc) and
for fastidious microorganisms (Brucella mellitensis, Mycobacterium avium).
Conclusion: DNIs represent a medical and surgical emergency and evidence-guided empirical treatment with
intravenous infusion of antibiotics at the time of diagnosis is mandatory, highlighting the importance of
epidemiological studies regarding the causative microorganisms. Although, in our study, the predominant
pathogens were S. pyogenes and S. aureus, the combination of culture and molecular assay revealed that
anaerobic bacteria play also a significant role in the pathogenesis of DNIs. Based on the local epidemiology,
we propose as empirical therapy the intravenous use of a beta-lactam /beta-lactamase inhibitor; metronidazole or
clindamycin can be added only in specific cases such as in immunocompromised patients.
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Background
Deep neck infections (DNIs) are defined by the presence
of inflammation with or without pus in the deep spaces
and fasciae of the head and neck. DNIs can be categorized
into parapharyngeal, infratemporal, pterygomaxillary, tem-
poral, parotid, masticator, submandibular, visceral, carotid
sheath, peritonsillar-pharyngeal mucosal, retropharyngeal,
danger and prevertebral spaces [1–3]. Despite the im-
provements of diagnostic tools (imaging and microbio-
logical techniques), DNIs continue to be fatal, especially in
immunocompromised patients or patients with significant
co-morbidities [4]. Their severity and extent can be over-
looked, often masquerading other infections (i.e. pharyn-
gitis, tonsillitis, torticollis etc), thus leading to delayed
diagnosis [5].
Adult DNIs more commonly involve multiple spaces,
leading to severe complications and appear to be more
serious compared to children [6]. In addition, use of an-
algesic, anti-inflammatory drugs and corticosteroids may
mask presentations by blunting immune responses. It is
sometimes difficult to trace the origin of the infection,
since the primary source of infection may precede by
weeks, given that the clinical manifestations are diverse
and depend on the affected spaces [7]. Even today, DNIs
continue to be fatal, leading to life-threatening complica-
tions such as airway compromise, pneumonia, pericardi-
tis, jugular vein thrombosis, mediastinal involvement.
Treatment principles consist of adequate resuscitation,
with surgical drainage of the neck and management of
complications, combined with appropriate antimicrobial
therapy. Although it is better to obtain cultures before the
antibiotic treatment, the patients often are empirically
treated, according to local and international guidelines.
In Greece, antimicrobial agents used for the treatment
of DNIs include the intravenous infusion, alone or in
combination, of penicillin, amoxicillin plus clavulanic
acid, ampicillin plus sulbactam, clindamycin and metro-
nidazole. However, the emergence and the spread of
multi-drug bacteria both in the nosocomial environment
and in the community emphasizes the need for a large
epidemiological survey focused on the etiology and on
the susceptibility of microorganisms that are the causa-
tive agents of DNIs.
The purpose of this study was to determine, during an
eight- years study period (October 2010–October 2018)
the identification and the susceptibility to antimicrobials
of microorganisms involved in DNIs in Central Greece,
in order to avoid clinical failure and misuse of
antibiotics.
Methods
Patients with DNIs
A study of data exported from a prospective database
was conducted on 610 consecutive patients with DNI
diagnosis, admitted from October 2010 until October
2018 in the Otolaryngology / Head & Neck Surgery
Department of University Hospital of Larissa, which
is the main tertiary hospital of Thessaly, Central
Greece. Thessaly is a rural area of Greece with about
1.000.000 inhabitants. The diagnosis of deep neck
abscess was suspected by clinical history and con-
firmed by Computed Tomography (CT) or surgery.
Demographic data (name, age, gender, residence, oc-
cupation, travel, previous hospitalization) and clinical
information (underlying disease, antibiotic therapy)
of the patients were collected. Clinical samples were
obtained, after admission and before starting anti-
biotic treatment, by needle aspiration or by sterile
swab using the BD ESwab™ collection and transport
system (Becton Dickinson) and were immediately
sent to the Microbiological Laboratory. The purulent
material was divided in two parts, one for Gram-stain and
culture and one for molecular assay.
Microbiological methods
Conventional methods: gram-stain, culture, identification
and antimicrobial susceptibility test
The specimens, after being tested by Gram-stain, were
cultured on two blood agar plates (one aerobically and
one anaerobically using BD BBL™ GasPak™ anaerobic),
on Mc Conkey agar and on Sabouraud agar for 5 days
at 37 °C. The identification of microorganisms to the
species level and the susceptibility testing was per-
formed by the VITEK®2 automated system (bioMér-
ieux, Marcy-l’Étoile, France). MICs were interpreted
according to the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) (http://www.eucast.org/
clinical_breakpoints/).
Molecular methods: 16S rRNA PCR followed by sequencing
analysis
In an effort to identify rapidly the causative agent of
DNIs, application of the 16S rRNA PCR was performed
directly to the specimens as previously reported [9].
Briefly, DNA was extracted using a QI Amp DNA Mini
kit (QIAGEN, Hilden, Germany), according to the in-
structions of the manufacturer. Then, the 16S rRNA
gene was amplified using the universal primers 5΄-
AGAGTTTGATCATGGCTCA-3΄ (forward; located at
positions 8 to 27) and 5΄-ACGGCGACTGCTGCTGGC
AC-3΄ (reverse; positions 531 to 514 Escherichia coli). In
the case where a band of approximately 520 bp was
obtained, PCR amplicons were sequenced in both direc-
tions in an ABI 3130 genetic analyzer and were com-
pared with those submitted to GenBank and EMBL,
using the BLAST algorithm.
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Statistical analysis
All descriptive data were reported in percentages. 2 × 2
contingency tables and Chi-Square tests were used to as-
sess potential correlations. Data analysis was performed
with the SPSS 20 statistical software (IBM, Chicago, IL,
USA) and values of p < 0.05 were considered as signifi-
cant results.
Results
Among the 610 patients with DNIs, 399 were male and
211 females (1,9/1 male to female ratio) with a mean
age ± SD of 39,24 ± 17,25 years. Among them, 564 were
adults (≥ 18 years old) and 46 children (< 18 years old).
In adults single space involvement was noticed in 534
patients (94,7%), and multi-space involvement in 30 pa-
tients (5,3%) (in 14 patients DNIs were located in more
than two neck spaces). Peritonsillar- pharyngeal mucosal
was the most common space involved (88,3%) followed
by submandibular space (7,2%). In children single space
involvement was noticed in 45 patients (97,8%) and
multi-space involvement in one patient (2,2%). Periton-
sillar was the most common space involved (86,9%)
followed by parapharyngeal space (6,5%) (Table 1).
All patients underwent either needle aspiration or sur-
gical drainage; cultures were taken before the empirical
antimicrobial therapy was started. In some cases the
treatment was modified properly after the results of sus-
ceptibility testing. Specimens for microbiological analysis
were obtained in 462 out of 610 patients (428 adults and
34 children), while 45,6% (210/462) of them (46,3% of
adults and 35,3% of children) had taken antibiotics be-
fore admission (Table 2). The most frequently antibiotics
used before admission were amoxicillin plus clavulanic
acid and clarithromycin (peros); empirical therapy in-
cluded intravenous infusion of ampicillin-sulbactam
combined with metronidazole or clindamycin. We note
that clinical samples for microbiological analysis were
not taken from 148 patients (24%), due mainly to the in-
sufficient purulent material.
From the 462 clinical specimens, 55,2% (255/462)
yielded positive cultures, while in 3 clinical samples two
different bacterial species were isolated; thus 258 bacter-
ial species were totally collected (see Tables 3 and 4).
Chi-Square tests did not demonstrate any significant dif-
ference (p > 0,05) between prior antibiotics uptake and
positive or negative culture results (Table 5), maybe due
to insufficient power. From the isolated bacteria species
91,9% (237/258) were aerobic and 8,1% (21/258) anaer-
obic. The most common aerobic bacteria were Strepto-
coccus pyogenes (45,3%) and Staphylococcus aureus (26,
7%). The most common anaerobic bacteria were Prevo-
tella melaninogenica (2,7%) and Fusobacterium nuclea-
tum (2,7%) (Table 3). No significant correlation was
noted in culture positivity from adults vs. children
Table 1 Demographics and spaces involved of the 610 patients
with deep neck infection
All patients (n = 610) male/female:
399/211
mean age ± SD:
39,24 ± 17,25
Space involved Single space (n = 579) Multi-space (n = 31)
- Peritonsillar-PMSa 516 5
- Submandibular 40 17
- Para-pharyngeal 10 20
- Retropharyngeal 7 6
- Masticator 3 6
- Parotid 3
- Visceral 6
- Ludwig’s angina 5
- Danger 5
- Carotid 1
Adults (n = 564) male/female: 378/186 mean age ± SD:
41,39 ± 16,06
Space involved Single space (n = 534) Multi-space (n = 30)
- Peritonsillar-PMS 476 4
- Submandibular 39 16
- Para-pharyngeal 7 20
- Retropharyngeal 6 6
- Masticator 3 6
- Parotid 3
- Visceral 6
- Ludwig’s angina 5
- Danger 5
- Carotid 1
Children (n = 46) male/female: 21/25 mean age ± SD:
12,8 ± 4,68
Space involved Single space (n = 45) Multi-space (n = 1)
- Peritonsillar-PMS 40 1
- Para-pharyngeal 3 1
- Retropharyngeal 1
- Submandibular 1
aPMS pharyngeal mucosal space
Table 2 Data of prior antibiotic therapy and culture results for
all our patients (children and adults)
Prior antibiotic therapy
No Yes Total
Culture results
Negative 112 95 207
Positive 140 115 255
Total 252 210 462
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(Pearson Chi-Square: 2301; P: 0,129 > 0.05 / Yate’s
Continuity Correction: 1790; P: 0,181 > 0.05 / Fisher’s
Exact Test: P: 0,153 > 0.05).
Regarding the susceptibility of aerobic Gram-positive
cocci to beta-lactams, all streptococci as anticipated were
susceptible to penicillin. Among staphylococci, 90% of S.
aureus isolates were resistant to penicillin and 3,9% were
methicillin-resistant (MRSA). High rate of resistance to
macrolides and lincosamides were observed in both S.
pyogenes and S. aureus isolates (17 and 19% respectively).
Aerobic Gram-negative bacteria expressed a wild-type
phenotype without additional acquired resistance mecha-
nisms. Finally, all anaerobic bacteria which were isolated
by culture, were susceptible to amoxicillin-clavulanic,
ampicillin-sulbactam, clindamycin and metronidazole.
Table 3 Distribution of the species isolated from the positive
cultures of adult (n = 232) and children (n = 23) with DNIs
patients. Three cultures were positive for two microorganisms
Adults (n = 232) Children (n = 23)
No (%) No (%)
Aerobic Bacteria 215 92,7 22 95,7
a. Gram-positive 207 89,2 19 82.6
1. Streptococcus pyogenes 104 44,8 13 56,5
2. Staphylococcus aureus 65 28 4 17,4
3. Streptococcus group C 23 9,9 1 4,3
4. Streptococcus anginosus 11 4,7 1 4,3
5. Streptococcus constellatus
subsp. pharynges
2 0,9
6. Streptococcus sanguinis 1 0,4
7. Staphylococcus epidermidis 1 0,4
b. Gram-negative 8 3,4 3 13
1. Pseudomonas aeruginosa 3 1,3
2. Klebsiella pneumoniae 2 0,9 1 4,3
3. Proteus mirabilis\ 2 0,9
4. Serratia liquefaciens 1 0,4
5. Providencia stuartii 2 8,7
Anaerobic Bacteria 20 8,6 1 4,3
a. Gram-positive 6 2,6 1 4,3
1. Parvimonas micra 5 2,2
2. Clostridium bifermentans 1 0,4 1 4,3
b. Gram-negative 14 6
1. Prevotella melaninogenica 7 3
2. Fusobacterium nucleatum 7 3
Table 4 The results of Chi-Square tests did not demonstrate any significant difference (p > 0,05) between prior antibiotics uptake
and positive or negative culture results
Value P
Asymptotic Significance
(2-sided)
P
Exact Significance
(2-sided)
P
Exact Significance
(1-sided)
Pearson Chi-Square 0,029 0,864
Yate’s Continuity Correction 0,006 0,939
Likelihood Ratio 0,029 0,864
Fisher’s Exact Test 0,925 0,469
Table 5 Detection of the bacterial species involved in DNIs of
adults and children (in 3 cultures two different bacteria species
were isolated)
Culture Culture +
16SrRNA
16SrRNA
Aerobic Bacteria 237 143 3a
a. Gram-positive 226 137
1. Streptococcus pyogenes 117 69
2. Staphylococcus aureus (2 MRSA) 69 50
3. Streptococcus group C 24 13
4. Streptococcus anginosus 12 5
5. Streptococcus constellatus subsp.
pharynges
2
6. Streptococcus sanguinis 1
7. Staphylococcus epidermidis 1
8. Brucella melitensis 2a
9. Mycobacteriun avium 1a
b. Gram-negative 11 6 –
1. Klebsiella pneumoniae 3 3
2. Pseudomonas aeruginosa 3 3
3. Providencia stuartii 2
4. Proteus mirabilis 2
5. Serratia liquefaciens 1
Anaerobic Bacteria 21 7 19a
a. Gram-positive 7 0 11a
1. Parvimonas micra 5
2. Clostridium bifermentans 2
3. Actinomyces israelii 11a
b. Gram-negative 14 7 8a
1. Prevotella melaninogenica 7 4
2. Fusobacterium nucleatum 7 3
3. Fusobacterium necrophorim 8a
aResults obtained only by 16S rRNA PCR
Beka et al. BMC Infectious Diseases          (2019) 19:850 Page 4 of 7
The application of 16S rRNA PCR directly to the spec-
imens revealed the presence of bacterial DNA in 183 out
462 samples (39,6%). One hundred-fifty of them (82%)
gave positive cultures; identification by sequencing ana-
lysis was in concordance with that obtained by conven-
tional methods. Results obtained by this molecular
method were available within 2 days after the sampling.
In addition, among the 33 samples (18%), that were PCR
positive but culture negative, 22 (12%) were found to be
positive for DNA of fastidious microorganisms, such as
Actinomyces israelii (11 out 22), F. necrophorum (8 out
22), Brucella melitensis (2 out 22) and Mycobacterium
avium (1 out 22). Regarding the remaining 11 samples
(6%), Sanger sequencing analysis failed to distinguish the
microorganisms involved, given that a polymicrobial
genetic pattern was obtained.
Discussion
DNIs are potentially fatal and require an aggressive
diagnostic and therapeutic management. In the pre-
antibiotic era, pharyngeal/tonsillar infection were responsible
for 70% of deep neck space infection [10, 11]. Usu-
ally, DNIs occur after previous uncontrolled infections
such as tonsillitis, dental infections, surgery, head and
neck trauma or lymphadenitis after upper airways in-
fection [4, 12], while, it is sometimes difficult to find
the origin of DNI because the primary source of in-
fection may precede it by weeks [7].
The management of DNIs involve surgical or needle
drainage of the abscess associated with the use of intra-
venous antibiotics [13–15]. DNIs require timely treat-
ment with IV antibiotics at the time of diagnosis because
of the rapidly progressive nature of these infections.
Antibiotic therapy should be empirically initiated, based
on local epidemiology, ideally before culture and sensi-
tivity results are available [1]. Until now, various empiric
antibiotics for deep neck infection have been proposed
[16–21]. This fact highlights the importance of epi-
demiological studies in DNIs microbiology, since these
studies help to determine the proper empirical treatment
in each geographical area. To our knowledge, this is the
first study in Greece focused on the etiology of DNIs.
According to our epidemiology, we propose as empir-
ical therapy the intravenous use of a beta-lactam /beta-
lactamase inhibitor; metronidazole or clindamycin can
be added only in specific cases such as in immunocom-
promised patients. Although clindamycin has a broad
range of activity against aerobic Gram-positive cocci and
anaerobic organisms, clinicians must be prudent with its
usage due to the increased rate of resistance. On the
other hand, metronidazole has excellent in vitro activity
against most obligate anaerobic bacteria (Bacteroides,
Fusobacterium, etc) but is inactive for Propionibacterium
acnes and Actinomyces israelii.
In the present study, cultures have obtained from 462
patients; 252 were unimicrobial, 3 were polymicrobial
and 207 were culture-negative. The microorganisms iso-
lated were bacteria that were part of the pharyngeal flora
such as S. pyogenes S. aureus, Streptococcus group C,
Streptococcus anginosus, Fusobacterium spp. and Prevo-
tella spp. Previous studies have also demonstrated that
S. pyogenes, S. aureus, Streptococcus viridans and Hae-
mophilus influenza are the most common bacterial spe-
cies [22–25]. The most common bacteria isolated were
S. pyogenes and S. aureus in adults and in children as
well. Most studies report a lower prevalence of DNI in
children compared to adults [3, 26, 27]. Probably this
may be caused by the history of antibiotics abuse, espe-
cially in colds and other viral infections, which are more
prevalent in children than in adults [28, 29]. In our study
children comprised 5,6% of total patients. According to
the literature, the effect of age on the distribution of bac-
teria causing DNI is not clear. Coticchia et al. have com-
pared the bacteriology between patients less than 1 year
and above 1 year of age and they have found that age
was a significant factor influencing bacteriology of DNI
[30]. On the other hand, other authors did not find any
significant differences in bacteriology of DNI between
various age groups. We point out that the incidence of
anaerobic bacteria was higher in adults compared to
children.
Finally, interesting finding was that 16S rRNA PCR
followed by sequencing analysis detected bacterial
DNA in 33 specimens that gave culture-negative re-
sults; 19 of them were found to be positive for anaer-
obic bacteria such as A. israelii and F. necrophorum.
Since none of these patients had taken antimicrobial
therapy before admission, the failure of the conven-
tional cultures to isolate these microorganisms could
be related to the inappropriate sample collection
combined with the fragility of the bacteria and the
short incubation time of the anaerobic culture. In
addition, 16S rRNA PCR identified correctly the
causative microorganisms which were isolated from
150 samples, while, the results obtained by the mo-
lecular methods were available sooner than that ob-
tained from cultures (mean time 2 versus 5 days).
However, this molecular assay failed to detect bacter-
ial DNA in 105 culture-positive samples, probably
due to the low microbial load. It is known that the
sensitivity of the 16S rRNA PCR, when it is applied
directly to the clinical samples, is depending on the
bacterial concentration. The culture of the low-
microbial load clinical samples combined with an
elongation of the time of incubation time enhances
the growth of microorganisms, giving more positive
results than the molecular method. Unfortunately, this
molecular approach, which uses the 16S rRNA PCR
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combined with Sanger analysis, is not able to identify
more than one microorganism per sample. Probably
in the future, the implementation of the next gener-
ation sequencing technology could solve this
limitation.
Conclusions
In conclusion, deep neck infections represent a medical
and surgical emergency, they are still common and can
develop serious complications. ‘Evidence-guided’ empir-
ical treatment with IV antibiotics at the time of diagno-
sis is mandatory, highlighting the importance of
epidemiological studies in DNIs microbiology. Although,
in our study, the main pathogens were S. pyogenes and S.
aureus, the combination of conventional and molecular
assays revealed that anaerobic bacteria play also a signifi-
cant role in the pathogenesis of DNIs. Based on the local
epidemiology, we propose as empirical therapy the intra-
venous use of a beta-lactam /beta-lactamase inhibitor;
metronidazole or clindamycin can be added only in spe-
cific cases such as in immunocompromised patients.
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